The package remained heavily equity-driven, with 306,406 RSUs and performance stock options tied to long-term results. ・Hims met 94% of its revenue target and 98% of its adjusted EBITDA target last ...

Digital healthcare continues to evolve across both direct-to-consumer and enterprise-focused platforms, with Hims & Hers ...

Hims & Hers Health Inc. (NYSE:HIMS) is one of the 10 Stocks With Monster Returns. Hims & Hers saw its share prices jump by 48 ...

Healthcare platforms report stronger-than-expected quarterly momentum Digital wellness demand continues reshaping sector ...

Hims & Hers Health, Inc. (HIMS) reached $29.76 at the closing of the latest trading day, reflecting a -4.03% change compared to its last close.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, ...

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses lately. The San Francisco, CA-based health and wellness platform’s stock has lost 55.8% compared with the ...

Hims & Hers Health is not out of the woods yet, sitting near yesterday's 17-month lows At last glance, shares of Hims & Hers Health Inc (NYSE:HIMS) are up 0.5% to trade at $15.91, after the wellness ...

If elected, the marketing leader from transformative companies like DoorDash and Meta will join a diverse board with medical, ...